(Governing the Algorithm — Article #2)
The Quiet Assumption Almost Every AI Vendor Makes
Ask a Healthcare AI founder to describe their governance, and most will describe their model: how it was trained, how it was validated, what its performance metrics look like. That's a real answer to a different question. It describes what the product does. It doesn't describe how the company manages the product once it's out in the world.
A model is an asset. Governance is the operating system that manages that asset — deciding what data it can learn from, who signs off on changes, how problems get detected, and who's accountable when something goes wrong.
What a Real Management System Actually Contains
Hospitals evaluating mature MedTech vendors are used to seeing a Quality Management System — a structured, documented, auditable framework, not a one-off validation report. For AI specifically, an equivalent management system needs to answer:
✔ Who owns model performance after launch, and how often is it reviewed?
✔ What triggers a retraining or update, and who has to approve it before it ships?
✔ How is a performance issue escalated, from first detection to resolution?
✔ What documentation exists to prove any of the above actually happened, versus being described only in a pitch deck?
A model can be excellent and still have none of this in place. That's the governance gap — not a bad product, but the absence of a system managing it.
Why This Gap Is Easy to Miss
Founders building Healthcare AI are, understandably, model-first by training and instinct. Data science teams optimize for performance metrics. Engineering teams optimize for uptime. Almost nobody on a lean early-stage team is explicitly tasked with owning the management system around the model, because it doesn't show up on a benchmark leaderboard and it doesn't ship as a feature.
The gap becomes visible only when someone outside the company asks for it directly:
"Can you show us your change-management process for model updates?"
A confident answer to that question is a governance artifact. A confident answer about accuracy alone is not.
What Hospitals Are Actually Buying
This is the shift that catches vendors off guard: increasingly, hospitals aren't purchasing a model's output. They're purchasing confidence that someone is accountable for that output over time.
A procurement or compliance reviewer isn't primarily asking "does this work?" — the clinical team has usually already answered that. They're asking "if this stops working as well as it did in the pilot, will we know, and will someone be responsible for fixing it?" That's a management-system question, not a model question.
Closing the Gap
Vendors who take this seriously tend to build a few concrete things early, not after a hospital asks:
-
A named owner (not "the team") for post-deployment model performance
-
A documented, repeatable process for reviewing and approving any model change
-
A basic audit trail showing that monitoring and review actually happened, not just that a policy exists
-
Clear escalation paths so a detected issue has a defined next step, not an ad hoc scramble
None of this requires new AI capability. It requires treating the management system as seriously as the model itself.
Final Thought
A model proves what the AI can do.
A management system proves the company can be trusted to manage what the AI does, indefinitely.
Hospitals don't just buy models.
They buy accountability.
Vendors who can show both — a capable model and a real system managing it — are the ones who move past pilot conversations into long-term institutional trust.
Next in the Governing the Algorithm Series:
Who's Actually Accountable When Your AI Is Wrong?
#HealthcareAI #AIGovernance #SaMD #QualityManagementSystem #Compliance #RiskManagement #DigitalHealth #HealthcareInnovation #ArtificialIntelligence #MedTech #QscriptionTechnologies